Banka BioLoo Limited (BANKA) Fair Value & Analysis
Industrials · IN · Market cap ₹1.0B
Fair value as of: Aug 2, 2026
From 14 valuation models · updated 11 days ago
Share price −8.0% over the past month.
Below-average quality, and screening another 89% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (₹9.32). The favourable scenario is already priced in.
- Weak quality (32/100) and above fair value at the same time, the margin of safety is missing on both counts.
- A fairly wide model range (₹4.97 to ₹9.32) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 2, 2026.
How to read this chart
60‑month range ₹41.97 – ₹161.95 · fair‑value band ₹4.97 – ₹9.32 · the ₹84.64 price screens above the ₹9.32 fair value. Dashed = 300-day average. As of Aug 2, 2026.
Analysis
Banka BioLoo Limited (BANKA) currently trades at ₹84.64, while our model-based Fair Value estimate is ₹9.32, implying the stock looks roughly 89.0% overvalued today. The Quality Score stands at 32/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Banka BioLoo Limited generated revenue of ₹571M at a net margin of 0.7%. Revenue grew 19.1% year over year. It earns a return on equity of 1.1%. Net debt stands at ₹298M. Fundamentals as of Aug 2, 2026
Our scenario range runs from ₹4.97 (bear case) to ₹9.32 (bull case); at ₹84.64, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 14% below its 52-week high and 106% above its 52-week low, currently above its 200-day average. For context, the median of 10 Industrials peers we cover trades at -46% fair-value upside, at -89%, BANKA screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 14 models by family
Widest divergence: Asset-Based (₹24.37) versus Multiples (₹7.59). Highest evidence: Residual Income (76).
Notify me when BANKA reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 2, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 31 · Market factors (momentum, volatility) 52
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Banka BioLoo Limited engages in the sanitation, fecal sludge, sewage, and wastewater treatment businesses in India. It is involved in the operation, setting up, and maintenance of fecal sludge, waste water, and effluent treatment plants.
Full company description
Banka BioLoo Limited engages in the sanitation, fecal sludge, sewage, and wastewater treatment businesses in India. It is involved in the operation, setting up, and maintenance of fecal sludge, waste water, and effluent treatment plants. The company also offers BioToilet, BioDigester, and FootLoo; packaged sewage treatment plant; and sewage treatment plant, as well as operations and management services. In addition, it is involved in manufacturing, supplying, and installation of bio toilets for Indian railways. The company provides its solutions for retail, residential, and commercial sectors. The company was incorporated in 2012 and is based in Hyderabad, India.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Banka BioLoo Limited reported revenue of ₹571M in FY2025 versus ₹388M in FY2021, a compound +10.2%/yr. Reported net income was ₹3.9M in FY2025, compounding −40.4%/yr from FY2021.
BANKA screens 89% overvalued. Compare with Veralto Corporation →
Peer Group
Pollution & Treatment Controls · 93 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Pollution & Treatment Controls median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Pollution & Treatment Controls stocks, each showing price versus our Fair Value estimate (as of Aug 2, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veralto Corporation VLTO | $94.21 | $69.11 | -27% |
| Zurn Elkay Water Solutions Corporation ZWS | $47.63 | $24.92 | -48% |
| Canmax Technologies Co 300390 | ¥57.02 | ¥10.41 | -82% |
| CECO Environmental Corp CECO | $83.63 | $15.19 | -82% |
| Fujian Longking Co 600388 | ¥17.58 | ¥15.59 | -11% |
| Munters Group MTRS | kr 166.60 | kr 16.90 | -90% |
| China Conch Venture Holdings 0586 | HK$8.83 | HK$14.14 | +60% |
| Mega Union Technology Inc 6944 | 1,005 TWD | 539.58 TWD | -46% |
| MayAir Technology (China) Co 688376 | ¥69.05 | ¥18.80 | -73% |
| Jingjin Equipment Inc 603279 | ¥12.80 | ¥18.97 | +48% |
Compare Banka BioLoo Limited with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is Banka BioLoo Limited (BANKA) overvalued or undervalued?
What is the fair value of BANKA?
What is the quality score of BANKA?
What is the revenue of Banka BioLoo Limited (BANKA)?
What is the net profit margin of BANKA?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Banka BioLoo Limited and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.